• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR

PARADIGM BIOPHARMACEUTICALS LIMITED..

0.00% ! 30.0¢
Market Cap $116.8M  !
Healthcare Biotechnology
Add to My Watchlist

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug... Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.More

Corporate Spotlight

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight arrow Created with Sketch.

PAR - close to a cure for osteoarthritis?

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAR
This peer is 34x PAR (!!) We need better street coverage! 		16:03 21 4.1K
16:03 Last post  Mozzarc Comments Created with Sketch.  21  Views Created with Sketch.  4.1K 
PAR
Where are we on a deal?
23 24 25
02:50 1.4K 486K
02:50 Last post  Upmarket Comments Created with Sketch.  1.4K  Views Created with Sketch.  486K 
PAR
PAR and the checklist... 		01:36 2 678
01:36 Last post  Figaraw Comments Created with Sketch.  2  Views Created with Sketch.  678 
PAR
compounding chemist 		19/06/25 46 16K
19/06/25 Last post  Mozzarc Comments Created with Sketch.  46  Views Created with Sketch.  16K 
PAR
Ann: PAR Receives US Ethics Approval for Phase 3 		18/06/25 55 21K
18/06/25 Last post  thenewinvest0r Comments Created with Sketch.  55  Views Created with Sketch.  21K 
PAR
The Ghosh Study - PART 1 		18/06/25 44 11K
18/06/25 Last post  Dungiven Comments Created with Sketch.  44  Views Created with Sketch.  11K 
PAR
PAR and the former bus driver, a comparison? 		11/06/25 13 4.6K
11/06/25 Last post  poolboy Comments Created with Sketch.  13  Views Created with Sketch.  4.6K 
PAR
outcomes of the meeting on 29 may
2
06/06/25 103 35K
06/06/25 Last post  Figaraw Comments Created with Sketch.  103  Views Created with Sketch.  35K 

See All Discussions arrow Created with Sketch.

Timeline

Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
03 Jun 08:41
 
Results of Meeting
29 May 17:10
 
PAR Receives US Ethics Approval for Phase 3
15 May 08:24
 
Notice of General Meeting/Proxy Form
29 Apr 16:57
 
March 2025 Quarterly Activities Report & Appendix 4C
29 Apr 13:51
 
Paradigm to present at NWR Healthcare Conference
18 Mar 15:02
 
View More arrow Created with Sketch.

Featured News

NEWS Infill Drilling at La Negra Returns High-Grade Silver with Standout 28m at 507gpt
right-arrow Created with Sketch.
DAL Maiden work program to commence for Blue Lagoon Zirconium, Niobium and Rare Earth Project in Greenland
right-arrow Created with Sketch.
NUZ Significant Blood-Brain Barrier Penetration Achieved by NUZ-001
right-arrow Created with Sketch.
NEWS Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms
right-arrow Created with Sketch.
STN Excellent Gold Intercepts Demonstrate Robust Apollo Hill Resource
right-arrow Created with Sketch.
NEWS Pilbara Exploration Identifies High-Grade Gold and Antimony Targets
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
30.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $116.8M
Open High Low Value Volume
30.0¢ 30.5¢ 29.5¢ $56.35K 188.1K

Buyers (Bids)

No. Vol. Price($)
1 9339 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 14285 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PAR (ASX) Chart

Top Stories

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Welcome to the end of another week. Let's forget commodities, stocks, and war for a moment, and look at inflation trajectories.
Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19 Amplia Therapeutics (ASX:ATX) has been the most watched on HotCopper forums through today after huge results from its ACCENT trials set up to look into how its FAK inhibitor, Narmafotinib, combats cancer.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest head...
Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19 Dreadnought Resources (ASX:DRE) has been the most watched on HotCopper forums through today after announcing an extension of its Mangaroon Gold Project in Western Australia.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week....
ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20 ASX 200 futures are pointing to a -0.2% slide at open today, after it emerged Donald Trump is pondering a direct attack on Iran @ a decision he says he’s going to ruminate on for @the next two weeks” before issuing orders.Listen to the HotCopper podcast for i...
AML3D opens new facility in Ohio as US Defence strategy bears fruit AML3D (ASX:AL3) has notched upward +4% in Friday morning trades as the US defence-focused 3D printing specilaist sets up...

Featured News

STN Excellent Gold Intercepts Demonstrate Robust Apollo Hill Resource
right-arrow Created with Sketch.
NEWS Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem
right-arrow Created with Sketch.
DAL Maiden work program to commence for Blue Lagoon Zirconium, Niobium and Rare Earth Project in Greenland
right-arrow Created with Sketch.
NEWS Infill Drilling at La Negra Returns High-Grade Silver with Standout 28m at 507gpt
right-arrow Created with Sketch.
NUZ Significant Blood-Brain Barrier Penetration Achieved by NUZ-001
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.
OSZAR »